| 前收盘价格 | 191.52 |
| 收盘价格 | 191.81 |
| 成交量 | 3,345,878 |
| 平均成交量 (3个月) | 1,531,970 |
| 市值 | 35,804,504,064 |
| 市盈率 (P/E TTM) | 25.92 |
| 预期市盈率 (P/E Forward) | 16.45 |
| 价格/销量 (P/S) | 2.37 |
| 股市价格/股市净资产 (P/B) | 5.14 |
| 52周波幅 | |
| 利润日期 | 12 Feb 2025 - 17 Feb 2025 |
| 营业毛利率 | 9.17% |
| 营业利益率 (TTM) | 14.84% |
| 稀释每股收益 (EPS TTM) | 7.83 |
| 季度收入增长率 (YOY) | 4.30% |
| 季度盈利增长率 (YOY) | -5.90% |
| 总债务/股东权益 (D/E MRQ) | 200.26% |
| 流动比率 (MRQ) | 0.810 |
| 营业现金流 (OCF TTM) | 2.58 B |
| 杠杆自由现金流 (LFCF TTM) | 2.00 B |
| 资产报酬率 (ROA TTM) | 5.11% |
| 股东权益报酬率 (ROE TTM) | 22.00% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Diagnostics & Research (US) | 混合的 | 混合的 |
| Diagnostics & Research (全球的) | 混合的 | 混合的 | |
| 股票 | IQVIA Holdings, Inc. | 看跌 | 看涨 |
AIStockmoo 评分
| 分析师共识 | 4.0 |
| 内部交易活动 | NA |
| 价格波动 | 4.5 |
| 技术平均移动指标 | -5.0 |
| 技术振荡指标 | -0.5 |
| 平均 | 0.75 |
|
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business. |
|
| 部门 | Healthcare |
| 行业 | Diagnostics & Research |
| 投资方式 | Mid Core |
| 内部持股比例 | 0.92% |
| 机构持股比例 | 94.53% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Mitsubishi Ufj Asset Management Co., Ltd. | 30 Sep 2024 | 2,379,300 |
| Cantillon Capital Management Llc | 30 Sep 2024 | 1,840,127 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 276.00 (Redburn Atlantic, 39.91%) | 购买 |
| 中 | 255.00 (29.26%) | |
| 低 | 212.00 (Baird, 7.47%) | 保留 |
| 平均值 | 253.80 (28.66%) | |
| 总计 | 14 购买, 1 保留 | |
| 平均价格@调整类型 | 207.93 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Stephens & Co. | 20 Dec 2024 | 250.00 (26.73%) | 购买 | 197.27 |
| B of A Securities | 13 Dec 2024 | 235.00 (19.13%) | 购买 | 199.06 |
| Truist Securities | 12 Dec 2024 | 261.00 (32.31%) | 购买 | 200.37 |
| 04 Nov 2024 | 265.00 (34.33%) | 购买 | 210.19 | |
| Baird | 11 Dec 2024 | 212.00 (7.47%) | 保留 | 201.07 |
| 01 Nov 2024 | 223.00 (13.04%) | 保留 | 209.16 | |
| RBC Capital | 11 Dec 2024 | 270.00 (36.87%) | 购买 | 201.07 |
| 04 Dec 2024 | 270.00 (36.87%) | 购买 | 203.17 | |
| Leerink Partners | 19 Nov 2024 | 248.00 (25.72%) | 购买 | 191.33 |
| JP Morgan | 05 Nov 2024 | 240.00 (21.66%) | 购买 | 212.87 |
| 23 Oct 2024 | 279.00 (41.43%) | 购买 | 228.31 | |
| Morgan Stanley | 04 Nov 2024 | 265.00 (34.33%) | 购买 | 210.19 |
| BTIG | 01 Nov 2024 | 260.00 (31.80%) | 购买 | 209.16 |
| Barclays | 01 Nov 2024 | 255.00 (29.26%) | 购买 | 209.16 |
| 15 Oct 2024 | 260.00 (31.80%) | 购买 | 232.98 | |
| Deutsche Bank | 01 Nov 2024 | 265.00 (34.33%) | 购买 | 209.16 |
| Goldman Sachs | 01 Nov 2024 | 250.00 (26.73%) | 购买 | 209.16 |
| TD Cowen | 01 Nov 2024 | 255.00 (29.26%) | 购买 | 209.16 |
| Redburn Atlantic | 14 Oct 2024 | 276.00 (39.91%) | 购买 | 233.22 |
| Evercore ISI Group | 08 Oct 2024 | 265.00 (34.33%) | 购买 | 226.72 |
| 显示更多 | ||||
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合